TH1338
TH1338 (compound 3b), an orally active camptothecin derivative and a potent chemotherapeutic agent for cancer, demonstrates excellent cytotoxic potency against human tumor cell lines in vitro. TH1338 (compound 3b) possesses significant brain penetration, favorable efflux pump properties, and hematological toxicity profile[1][2].
Product Specifications
CAS Number
1258494-60-8
UNSPSC
12352005
Hazard Statement
H301
Target
ADC Payload; Topoisomerase
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/th1338.html
Purity
98.77
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(CC)C5=CC=CC=C5N=C4C3=C2N)=O
Molecular Formula
C22H21N3O4
Molecular Weight
391.42
Precautions
H301
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GREM2 (Gremlin-2, Cysteine Knot Superfamily 1, BMP Antagonist 2, DAN Domain Family Member 3, Protein Related to DAN and Cerberus, CKTSF1B2, DAND3, PRDC, FLJ21195)
FGF19 (Fibroblast Growth Factor 19, FGF-19, UNQ334/PRO533) (Biotin)
RING Finger Protein 133 (RNF133, E3 Ubiquitin-protein Ligase RNF133) (MaxLight 550)
Ulk3, ID (Ulk3, Serine/threonine-protein kinase ULK3, Unc-51-like kinase 3) (PE) discontinued
C-Met (Hepatocyte Growth Factor Receptor, Scatter Factor Receptor, HGFR, SFR) (PE) discontinued